Awakn Life Sciences Corp.
Awakn Life Sciences Corp.
Awakn Life Sciences Corp. is a clinical-stage biotechnology company developing medication-assisted treatments for addiction. Awakn has a near-term focus on Alcohol Use Disorder (AUD), a condition affecting approximately 51 million people in the US and key European markets and 285 million people globally for which the current standard of care is inadequate. Our goal is to provide breakthrough therapeutics to addiction sufferers in desperate need and our strategy is focused on commercializing our R&D pipeline across multiple channels.
Awakn Life Sciences Corp. (AWKN)
SEDAR Information
Company Info
Capitalization
Company Officers
Bulletins
2024-0530 - Reinstatement - Awakn Life Sciences Corp. (AWKN)
le 31 mai/May 2024
Effective immediately, Awakn Life Sciences Corp. will be reinstated for trading.
The Company has rectified the situation that gave rise to the suspension.
____________________________
Avec effet immédiat, Awakn Life Sciences Corp. sera réintégrée à la négociation.
La Société a rectifié la situation qui a donné lieu à la suspension.
